Search
  • 网站搜寻
亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。
返回搜索结果

A-18 Novel Method to Produce Mesenchymal Stem Cells


技术优势

ΓùÅ Novel: This is a novel method to isolate ADSCs from adipose cellsΓùÅ Patient-Friendly: ADSCs can be produced from patientΓÇÖs own embryo or skin cellsΓùÅ Diversified Applications: ADSCs can be differentiated into adipose, osteoblast, skeletal muscle and chondrocytes.


技术应用

ΓùÅ Regenerative medicine (adipose, osteoblast, skeletal muscle and chondrocyte)ΓùÅ Transplantation for arterial sclerosis, cardial infarcts, hepatocirrhosis, diabetes, ParkinsonΓÇÖs disease and muscular dystrophy patientsΓùÅ Research tools for lab technicians


详细技术说明

None


附加资料

Inventor: TORIHASHI, Shigeko | NINAGAWA, Nana
Priority Number: WO2009128533A1
IPC Current: C12N00050775 | C12N000510
Assignee Applicant: National University Corporation Nagoya University
Title: MESENCHYMAL STEM CELL AND METHOD FOR PRODUCTION THEREOF | CELLULE SOUCHE MÉSENCHYMATEUSE ET SON PROCÉDÉ DE PRODUCTION
Usefulness: MESENCHYMAL STEM CELL AND METHOD FOR PRODUCTION THEREOF | CELLULE SOUCHE MÉSENCHYMATEUSE ET SON PROCÉDÉ DE PRODUCTION
Summary: The cell culture product is useful in regeneration medicine for treating diseases such as life-style related diseases, e.g. arteriosclerosis, myocardial infarction, liver cirrhosis, diabetes, Parkinson's disease and muscular dystrophy.
Novelty: Cell culture product in regeneration medicine for treating diseases e.g. diabetes, comprises mesenchymal stem cell of cluster of differentiation 105 positive cell differentiated from pluripotent stem cell derived from human or animal


主要类别

生物医学


细分类别

生物工程


国家/地区

美国

欲了解更多信息,请点击 这里
Business of IP Asia Forum
桌面版